Related Experiment Video
Updated: Jul 12, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Identifying Predominant Causes of Death Among Hospitalized COVID-19 Patients During Poland's Second and Third Waves
Irina Niecwietajewa1, Michał Frączek2, Maria Mroczkowska3
1Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland.
Insights
This study found a 35% mortality rate among 581 hospitalized COVID-19 patients in Poland from November 2020 to May 2021. Leading causes of death included lung damage and bacterial superinfections, highlighting severe COVID-19 morbidity and mortality.
Area of Science:
- Infectious Diseases
- Epidemiology
- Critical Care Medicine
Background:
- Poland experienced high COVID-19 mortality rates in Europe between November 2020 and May 2021.
- This study investigated morbidity and mortality in hospitalized COVID-19 patients during this period.
Purpose of the Study:
- To evaluate morbidity and mortality rates in patients hospitalized with severe COVID-19.
- To identify primary causes of death in hospitalized COVID-19 patients.
Main Methods:
- A retrospective, single-center study analyzed data from 581 hospitalized COVID-19 patients.
- Charlson Comorbidity Index assessed multimorbidity; COVID-19 diagnosis confirmed by RT-PCR.
- Statistical analysis performed using IBM SPSS Statistics.
Main Results:
- The overall mortality rate was 35% among admitted patients.
- Leading causes of death were lung damage (60%), bacterial superinfection (26%), and thromboembolism (9%).
- A significant relationship was found between sex and cause of death (COVID-19 pneumonia, VAP).
Conclusions:
- Severe COVID-19 patients faced high morbidity and mortality before widespread vaccination and effective treatments.
- Findings underscore the critical impact of COVID-19 during the study period.
- Bacterial superinfections and lung damage were significant contributors to mortality.
Abstract:
BACKGROUND Number of confirmed COVID-19 deaths per million population in Poland between November 2020 and May 2021 was one of the largest in Europe. This retrospective study was conducted at a single center in Poland between November 2020 and May 2021to evaluate the morbidity and mortality rates in 581 patients hospitalized with COVID-19. MATERIAL AND METHODS A retrospective single-center study was conducted in a dedicated COVID-19 hospital from November, 2020 to May, 2021. The data of 581 hospitalized patients were analyzed. Multimorbidity was assessed using the Charlson Comorbidity Index, including chronic kidney, respiratory, cardiovascular diseases, diabetes mellitus, cancer, and dementia. The observation period covered admission to the hospital for severe COVID-19 until discharge or death. Diagnosis of COVID-19 was confirmed by quantitative reverse transcription polymerase chain reaction test. Statistical analysis was carried out in the IBM SPSS Statistics program. RESULTS The mortality rate was 35% of all admitted patients. Lung damage was the cause of death in 60%, bacterial superinfection in 26%, arterial thrombosis or thromboembolism in 9%, and heart failure in 5% of patients. The chi-square test showed a significant relationship between sex and the cause of death related to COVID-19 pneumonia and bacterial ventilator-associated pneumonia (VAP). CONCLUSIONS The findings from this study supports findings from other countries that between November 2020 and May 2021, before SARS-CoV-2 vaccination programs were fully implemented and before effective medications and antiviral agents were developed, patients with severe COVID-19 had high rates of morbidity and mortality.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia II: Pathophysiology
Other Pulmonary Disorders
Coronary Artery Disease III: Clinical Manifestations

